Thomas Arnesen

About Thomas Arnesen

Thomas Arnesen, With an exceptional h-index of 48 and a recent h-index of 34 (since 2020), a distinguished researcher at Universitetet i Bergen, specializes in the field of protein modifications, cancer, acetylation, acetyltransferases, protein termini.

His recent articles reflect a diverse array of research interests and contributions to the field:

Protein N-terminal acetylation is entering the degradation end game

Biallelic NAA60 variants with impaired n-terminal acetylation capacity cause autosomal recessive primary familial brain calcifications

Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice

Naa80 is required for actin N-terminal acetylation and normal hearing in zebrafish

Using cell lysates to assess N-terminal acetyltransferase activity and impairment

Expanded in vivo substrate profile of the yeast N-terminal acetyltransferase NatC

Preface: A nascent polypeptide emerges.

Structural properties of the HNF-1A transactivation domain

Thomas Arnesen Information

University

Position

Professor Department of Biomedicine

Citations(all)

7983

Citations(since 2020)

4313

Cited By

5464

hIndex(all)

48

hIndex(since 2020)

34

i10Index(all)

82

i10Index(since 2020)

71

Email

University Profile Page

Google Scholar

Thomas Arnesen Skills & Research Interests

protein modifications

cancer

acetylation

acetyltransferases

protein termini

Top articles of Thomas Arnesen

Protein N-terminal acetylation is entering the degradation end game

2024/3/22

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Biallelic NAA60 variants with impaired n-terminal acetylation capacity cause autosomal recessive primary familial brain calcifications

Nature communications

2024/3/13

Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice

bioRxiv: the preprint server for biology

2024/1/10

Naa80 is required for actin N-terminal acetylation and normal hearing in zebrafish

bioRxiv

2024

Using cell lysates to assess N-terminal acetyltransferase activity and impairment

Modifications and targeting of protein termini Part B

2023/3/24

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Expanded in vivo substrate profile of the yeast N-terminal acetyltransferase NatC

Journal of Biological Chemistry

2023/2/1

Preface: A nascent polypeptide emerges.

Methods in Enzymology

2023/1/1

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Structural properties of the HNF-1A transactivation domain

Frontiers in Molecular Biosciences

2023

Optimized bisubstrate inhibitors for the actin N-terminal acetyltransferase NAA80

Frontiers in Chemistry

2023

Markus Baumann
Markus Baumann

H-Index: 9

Thomas Arnesen
Thomas Arnesen

H-Index: 34

A nonsense variant in the N‐terminal acetyltransferase NAA30 may be associated with global developmental delay and tracheal cleft

American Journal of Medical Genetics Part A

2023/9

Sylvia Varland
Sylvia Varland

H-Index: 8

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Novel biallelic variants expand the phenotype of NAA20‐related syndrome

Clinical Genetics

2023/9

Antonietta Coppola
Antonietta Coppola

H-Index: 21

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Modifications and targeting of protein termini Part B

2023/7/31

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Loss of N-terminal acetyltransferase A activity induces thermally unstable ribosomal proteins and increases their turnover in Saccharomyces cerevisiae

Nature Communications

2023/7/27

NATs at a glance

2023/7/15

Henriette Aksnes
Henriette Aksnes

H-Index: 10

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Actin finally matures: uncovering machinery and impact

2023/5/1

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Henriette Aksnes
Henriette Aksnes

H-Index: 10

Protein Termini 2022: central roles of protein ends

2023/3/29

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Henriette Aksnes
Henriette Aksnes

H-Index: 10

Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation

Human Genetics

2022/8

Thomas Arnesen
Thomas Arnesen

H-Index: 34

Structural and biophysical characterization of transcription factor HNF-1A as a tool to study MODY3 diabetes variants

Journal of Biological Chemistry

2022/4/1

Petri Kursula
Petri Kursula

H-Index: 22

Thomas Arnesen
Thomas Arnesen

H-Index: 34

The final maturation state of β-actin involves N-terminal acetylation by NAA80, not N-terminal arginylation by ATE1

Journal of molecular biology

2022/1/30

See List of Professors in Thomas Arnesen University(Universitetet i Bergen)

Co-Authors

academic-engine